 Two strong and one weak promoters were predicted to be present in the "CLCN5" gene.Several different 5’ alternatively used exons have been recognized in the human kidney.The three promoters drive with varying degree of efficiency 11 different mRNAs, with transcription initiating from at least three different start sites.